NOTE: This disposition is nonprecedential. United States Court of Appeals
for the Federal Circuit
CEPHALON, INC., EAGLE PHARMACEUTICALS,
INC., TEVA PHARMACEUTICALS
INTERNATIONAL GMBH,
Plaintiffs-Appellees
v.
SLAYBACK PHARMA LLC, FRESENIUS KABI USA,
LLC
Defendants
APOTEX INC., APOTEX CORP., MYLAN
LABORATORIES LIMITED,
Defendants-Appellants
2020-2134, 2020-2137
Appeals from the United States District Court for the District of Delaware in Nos. 1:17-cv-01154-CFC, 1:17-cv-01164-CFC, 1:17-cv-01201-CFC, 1:17-cv-01790-CFC, Judge Colm F. Connolly.
JUDGMENT
DAVID I. BERL, Williams & Connolly LLP, Washington, DC, argued for all plaintiffs-appellees. Plaintiffs-appellees
2Cephalon, Inc., Teva Pharmaceuticals International GmbH also represented by ADAM HARBER, MATTHEW LACHMAN, SHAUN PATRICK MAHAFFY, BEN PICOZZI.
DANIEL BROWN, Latham & Watkins LLP, New York, NY, for plaintiff-appellee Eagle Pharmaceuticals, Inc. Also represented by GABRIEL K. BELL, Washington, DC; KENNETH G. SCHULER, MARC NATHAN ZUBICK, Chicago, IL. STEVEN ERIC FELDMAN, Hahn Loeser & Parks, LLP, Chicago, IL, argued for defendants-appellants Apotex Inc., Apotex Corp. Also represented by DANIEL RONALD CHERRY, JOHN CRAVERO, SHERRY LEE ROLLO.
NICOLE W. STAFFORD, Wilson, Sonsini, Goodrich & Rosati, Austin, TX, argued for defendant-appellant Mylan Laboratories Limited. Also represented by ADEN M. ALLEN; DENNIS DONALD GREGORY, New York, NY; DAVID S. STEUER, Palo Alto, CA.
THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:
Circuit Judges).
AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY ORDER OF THE COURT
August 13, 2021 /s/ Peter R. Marksteiner
Date Peter R. Marksteiner
Clerk of Court